ECSP055546A - Derivados novedosos de piridiletanol (feniletil) aminas como inhibidores de la biosíntesis de colesterol, procesos para su preparación, y composiciones farmaceuticas que los contienen - Google Patents
Derivados novedosos de piridiletanol (feniletil) aminas como inhibidores de la biosíntesis de colesterol, procesos para su preparación, y composiciones farmaceuticas que los contienenInfo
- Publication number
- ECSP055546A ECSP055546A EC2005005546A ECSP055546A ECSP055546A EC SP055546 A ECSP055546 A EC SP055546A EC 2005005546 A EC2005005546 A EC 2005005546A EC SP055546 A ECSP055546 A EC SP055546A EC SP055546 A ECSP055546 A EC SP055546A
- Authority
- EC
- Ecuador
- Prior art keywords
- cholesterol
- carbon atoms
- biosynthesis
- derivatives
- piridiletanol
- Prior art date
Links
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 title abstract 6
- 235000012000 cholesterol Nutrition 0.000 title abstract 3
- 230000015572 biosynthetic process Effects 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 abstract 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 abstract 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical group [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical group FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 1
- 208000035150 Hypercholesterolemia Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 abstract 1
- 229910052794 bromium Inorganic materials 0.000 abstract 1
- 239000000460 chlorine Chemical group 0.000 abstract 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- 201000005577 familial hyperlipidemia Diseases 0.000 abstract 1
- 239000011737 fluorine Chemical group 0.000 abstract 1
- 229910052731 fluorine Inorganic materials 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 239000003982 sigma receptor ligand Substances 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Se describen los derivados novedosos de piridil-etanol-(feniletil)-aminas de la fórmula I:en donde: n es un entero de 1 a 4, R1 es un átomo de hidrógeno, un grupo hidroxilo, o un grupo alcoxilo inferior de 1 a 6 átomos de carbono, R2 es un átomo de hidrógeno o un grupo alquilo inferior de 1 a 6 átomos de carbono recto o ramificado, X es hidrógeno, flúor, cloro, bromo, un grupo hidroxilo, un grupo trifluorometilo, 3,4-di-Cl-2,4-di-Cl ó un grupo alcoxilo inferior de 1 a 6 átomos de carbono, los enantiómeros, diaestereoisómeros, o racematos de los mismos, o las sales de adición de ácido fisiológica-mente aceptables de los mismos, que son los ligandos de los receptores sigma para inhibir la biosíntesis de colesterol, y por lo tanto, son apropiados para el tratamiento de hipercolesterolemia a hiperlipemia en seres humanos. Se observó la mayor disminución de colesterol mediante el 1-(3-piridil)2-(N-(2-(3,4-diclorofenil)etil-N-propilamino)-etanol en la forma de la sal de dibromhidrato (firma BK-35.2HBr).
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SI200200177A SI21268A (sl) | 2002-07-17 | 2002-07-17 | Novi derivati piridiletanol (feniletil) aminov kot inhibitorjev biosinteze holesterola, postopki za njihovo pripravo in farmacevtski pripravki, ki jih vsebujejo |
| SI200200287A SI21368A (sl) | 2002-11-28 | 2002-11-28 | Novi derivati piridiletanol (feniletil) aminov kot inhibitorjev biosinteze holesterola, postopki za njihovo pripravo in farmacevtski pripravki, ki jih vsebujejo |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP055546A true ECSP055546A (es) | 2005-05-30 |
Family
ID=30117598
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EC2005005546A ECSP055546A (es) | 2002-07-17 | 2005-01-17 | Derivados novedosos de piridiletanol (feniletil) aminas como inhibidores de la biosíntesis de colesterol, procesos para su preparación, y composiciones farmaceuticas que los contienen |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US7560474B2 (es) |
| EP (1) | EP1546105A1 (es) |
| JP (1) | JP4567448B2 (es) |
| KR (1) | KR100645412B1 (es) |
| CN (1) | CN1297540C (es) |
| AU (1) | AU2003248614B2 (es) |
| BR (1) | BR0312945A (es) |
| CA (1) | CA2493004A1 (es) |
| EC (1) | ECSP055546A (es) |
| IL (1) | IL166191A (es) |
| MX (1) | MXPA05000663A (es) |
| NO (1) | NO330010B1 (es) |
| NZ (1) | NZ537635A (es) |
| PL (1) | PL373429A1 (es) |
| RU (1) | RU2309949C2 (es) |
| WO (1) | WO2004007456A1 (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017021002A1 (en) * | 2015-07-31 | 2017-02-09 | Laboratorios Del Dr. Esteve, S.A. | Use of sigma receptor ligands in dyslipidemia |
| CN114652735A (zh) | 2016-07-27 | 2022-06-24 | 凯斯西储大学 | 促进髓鞘形成的化合物和方法 |
| BR112020025987A2 (pt) | 2018-06-21 | 2021-03-23 | Yumanity Therapeutics, Inc. | composições e métodos para tratamento e prevenção de distúrbios neurológicos |
| WO2021247910A1 (en) * | 2020-06-03 | 2021-12-09 | Yumanity Therapeutics, Inc. | Amino alcohol compounds and uses thereof |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2786846A (en) * | 1953-06-01 | 1957-03-26 | Reilly Tar & Chem Corp | Process of alkylating pyridines |
| US2792403A (en) * | 1955-01-05 | 1957-05-14 | Univ Michigan | 2-pyridylethyl-phenylethylalkylamines |
| GB1188154A (en) * | 1966-05-28 | 1970-04-15 | Egyt Gyogyszervegyeszeti Gyar | New Pyridine Derivatives and process for their preparation |
| GB1417029A (en) * | 1973-03-07 | 1975-12-10 | Pfizer Ltd | Quinazoline-derived amines |
| JPS5840539B2 (ja) * | 1976-03-31 | 1983-09-06 | 大塚製薬株式会社 | α−置換アミノアルカノイルオキシインド−ル誘導体 |
| DE2817494A1 (de) * | 1977-05-03 | 1978-11-09 | Continental Pharma | Aminoalkohol-derivat |
| ZA821436B (en) * | 1981-03-06 | 1983-02-23 | Beecham Group Plc | Secondary amines |
| CA1287061C (en) * | 1986-06-27 | 1991-07-30 | F. Hoffmann-La Roche Ag | Pyridine ethanolamine derivatives |
| ZA874449B (en) * | 1986-06-27 | 1987-12-28 | F. Hoffmann-La Roche & Co. Aktiengesellschaft | Pyridine ethanolamine derivatives |
| DE3729284A1 (de) * | 1987-09-02 | 1989-03-23 | Thomae Gmbh Dr K | Neue heteroarylethanolamine, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
| CA2071897A1 (en) * | 1989-12-28 | 1991-06-29 | Richard A. Glennon | Sigma receptor ligands and the use thereof |
| US5254549A (en) * | 1991-12-19 | 1993-10-19 | Merz & Co. Gmbh & Co. | New BHT ether compounds and their use as hypolipidemic and antiatherosclerotic drugs |
| GB2305665A (en) * | 1995-09-26 | 1997-04-16 | Merck & Co Inc | Selective ß3 agonists for the treatment of diabetes aand obesity |
| GB9812709D0 (en) * | 1998-06-13 | 1998-08-12 | Glaxo Group Ltd | Chemical compounds |
| AUPP796798A0 (en) * | 1998-12-30 | 1999-01-28 | Fujisawa Pharmaceutical Co., Ltd. | New compound |
| DK1859798T3 (en) * | 2001-03-29 | 2016-03-21 | Lilly Co Eli | N- (2-arylethyl) -BENZYLAMINER as antagonists of 5-HT6 receptor |
-
2003
- 2003-07-09 EP EP03764285A patent/EP1546105A1/en not_active Withdrawn
- 2003-07-09 WO PCT/SI2003/000021 patent/WO2004007456A1/en not_active Ceased
- 2003-07-09 BR BR0312945-4A patent/BR0312945A/pt not_active IP Right Cessation
- 2003-07-09 NZ NZ537635A patent/NZ537635A/en not_active IP Right Cessation
- 2003-07-09 JP JP2004521370A patent/JP4567448B2/ja not_active Expired - Fee Related
- 2003-07-09 RU RU2005104420/04A patent/RU2309949C2/ru not_active IP Right Cessation
- 2003-07-09 CN CNB038168502A patent/CN1297540C/zh not_active Expired - Fee Related
- 2003-07-09 MX MXPA05000663A patent/MXPA05000663A/es active IP Right Grant
- 2003-07-09 AU AU2003248614A patent/AU2003248614B2/en not_active Ceased
- 2003-07-09 PL PL03373429A patent/PL373429A1/xx not_active Application Discontinuation
- 2003-07-09 KR KR1020057000707A patent/KR100645412B1/ko not_active Expired - Fee Related
- 2003-07-09 CA CA002493004A patent/CA2493004A1/en not_active Abandoned
- 2003-07-09 US US10/521,294 patent/US7560474B2/en not_active Expired - Fee Related
-
2005
- 2005-01-06 IL IL166191A patent/IL166191A/en not_active IP Right Cessation
- 2005-01-17 EC EC2005005546A patent/ECSP055546A/es unknown
- 2005-02-16 NO NO20050833A patent/NO330010B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003248614B2 (en) | 2007-08-30 |
| CA2493004A1 (en) | 2004-01-22 |
| CN1297540C (zh) | 2007-01-31 |
| EP1546105A1 (en) | 2005-06-29 |
| PL373429A1 (en) | 2005-08-22 |
| KR100645412B1 (ko) | 2006-11-15 |
| IL166191A (en) | 2010-12-30 |
| WO2004007456A1 (en) | 2004-01-22 |
| JP4567448B2 (ja) | 2010-10-20 |
| RU2309949C2 (ru) | 2007-11-10 |
| NZ537635A (en) | 2006-11-30 |
| US7560474B2 (en) | 2009-07-14 |
| NO330010B1 (no) | 2011-02-07 |
| CN1668594A (zh) | 2005-09-14 |
| IL166191A0 (en) | 2006-01-15 |
| RU2005104420A (ru) | 2005-10-10 |
| NO20050833L (no) | 2005-04-18 |
| KR20050026480A (ko) | 2005-03-15 |
| MXPA05000663A (es) | 2005-09-20 |
| BR0312945A (pt) | 2005-07-12 |
| JP2005538081A (ja) | 2005-12-15 |
| AU2003248614A1 (en) | 2004-02-02 |
| US20050256172A1 (en) | 2005-11-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20040686B1 (hr) | Novi heterocikliäśki spojevi koji djeluju kao inhibitori beta-laktamaza | |
| NO20085060L (no) | Triazolpyrazinderivater anvendelige som anti-cancermidler | |
| NO20062689L (no) | Azabisykliske heterosykler som modulatorer for kannabinoidreseptorer | |
| DK1313695T3 (da) | Estere af 5-aminolevulinsyre som fotosensibiliserende midler i fotokemoterapi | |
| NO20062704L (no) | Azabicykliske heterocykler som cannabinoide reseptormodulatorer | |
| NO20060324L (no) | [1,8]Naftyridin-2-oner og relaterte forbindelser for behandling av Schizofreni | |
| EA201000805A1 (ru) | Бис-(сульфониламино)производные в терапии 066 | |
| DOP2001000170A (es) | Derivados de tiofeno utiles como agentes anticancesoros | |
| UY27952A1 (es) | Nuevos derivados de benzoimidazol útiles como agentes antiproliferativos | |
| NO20051826L (no) | Heterosyklisk substituerte piperaziner for behandling av schizofreni | |
| NO20065456L (no) | Substituerte morfolinforbindelser for behandling av sykdommer i sentralnervesystemet | |
| SG151260A1 (en) | 5-substituted-2-phenylamino-benzamides as mek inhibitors | |
| NO20084516L (no) | Terfenylderivater for behandling av alzheimers sykdom | |
| NO20050134L (no) | Difenylazetidioner substituert med syregrupper, fremgangsmate for fremstilling av disse, medikamenter inneholdende disse forbindelser og deres anvendelse | |
| HRP20080175T3 (hr) | Supstituirani 2-aminotetrtalini, namijenjeni preventivnom liječenju parkinsonove bolesti | |
| NO20071109L (no) | Indol-2-karboksamidinderivater som NMDA-reseptorantagonister | |
| NO20045486L (no) | Nye forbindelser og deres anvendelse | |
| ATE431345T1 (de) | Als modulatoren von dopamin-d3-rezeptoren geeignete azabicyclo-(3,1,0)-hexan-derivate | |
| ATE372995T1 (de) | Benzo(b)(1,4)dioxepinderivate | |
| MX2009004884A (es) | Derivados 8-piperidinil-2-piridinil-pirimido [1,2-a] pirimidin-6-ona y 8-piperidinil-2-pirimidinil-pirimido [1,2-a] pirimidin-6-ona sustuidos. | |
| UY27685A1 (es) | Indolil-urea derivados de tienopiridinas útiles como agentes antiangiogénicos, y procedimientos para su uso | |
| NO20082214L (no) | 1,1-Diokso-tiomorfolinyl-indolyl-metanonderivater for anvendelse som H3-modulatorer | |
| ECSP055546A (es) | Derivados novedosos de piridiletanol (feniletil) aminas como inhibidores de la biosíntesis de colesterol, procesos para su preparación, y composiciones farmaceuticas que los contienen | |
| ZA200704913B (en) | 3-[2-(3-acylamino-2-oxo-2H-pyridin-1-YL)-acetylamino]-4-oxo-pentanoic acid derivatives and their use as caspase inhibitors | |
| NO20063865L (no) | Heterocyklisk substituerte 7-amino-4-kinolon-3-karboksylsyrederivater, fremgangsmate for fremstilling derav og deres anvendelse som medikamenter |